Geode Capital Management »

Carmell Therapeutics Corp - US shares owned by Geode Capital Management

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $39k 98k 0.40
2024-06-30 $111k 83k 1.33
2024-03-31 $230k 90k 2.56
2023-09-30 $224k 62k 3.60

More positions owned by Geode Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)
Visa Inc-class A Shares Com Cl A (V)

View all positions for Geode Capital Management

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Tower Research Capital
Morgan Stanley
Bank of America Corporation

View all funds holding Carmell Therapeutics Corp - US